Provided by Tiger Fintech (Singapore) Pte. Ltd.

TIGERMED

51.650
-1.350-2.55%
Volume:1.30M
Turnover:67.29M
Market Cap:44.47B
PE:100.52
High:53.250
Open:52.450
Low:51.000
Close:53.000
52wk High:60.600
52wk Low:22.121
Shares:861.00M
HK Float Shares:123.00M
Volume Ratio:0.44
T/O Rate:1.06%
Dividend:0.33
Dividend Rate:0.64%
EPS(LYR):0.514
ROE:1.05%
ROA:1.43%
PB:1.98
PE(LYR):100.52
PS:6.25

Loading ...

TIGERMED to Hold First Extraordinary General Meeting of 2025 on September 29

Deep News
·
Yesterday

JPMorgan Increases Holdings in TIGERMED (03347) by 343,700 Shares at Approximately HK$46.98 Per Share

Stock News
·
Sep 04

BOC International Raises TIGERMED (03347) Target Price to HK$51, Maintains "BUY" Rating

Stock News
·
Sep 03

HK Movers|Biopharmaceutical Stocks Rallied. BeiGene up 9%; 3SBio And Tigermed Up Over 4%; Wuxi XDC Increasing More Than 3%

Tiger Newspress
·
Sep 02

Lyon Cuts TIGERMED Target Price to HK$58.9, Downgrades Earnings Forecasts

Stock News
·
Sep 01

Bank of America Securities Raises TIGERMED Target Price to HK$56, Reiterates "Buy" Rating

Stock News
·
Sep 01

AH Premium Statistics | August 29

Stock News
·
Aug 29

TIGERMED (03347): Executive Director Wu Hao Elected as Employee Director for Fifth Board of Directors

Stock News
·
Aug 28

AH Stock Statistics | August 26

Stock News
·
Aug 26

AH Share Premium Statistics | August 20th

Stock News
·
Aug 20

Societe Generale Asset Management Reduces TIGERMED (03347) Holdings by 345,400 Shares at HK$58.45 Per Share

Stock News
·
Aug 19

HK Movers | Biotech Shares Soar. RemeGen up 16%; JW Therapeutics up 10%; Junshi Bio up 6%

Tiger Newspress
·
Aug 14

E Fund Management Increases Holdings in TIGERMED (03347) by 1.1816 Million Shares at Approximately HK$55.91 Per Share

Stock News
·
Aug 04

Vcanbio Cell&Gene Engineering Corp.,Ltd. (600645.SH) Subsidiary Receives Clinical Trial Acceptance Notice for VUM02 Injection

Stock News
·
Aug 04

Bio-Thera Solutions,Ltd. (688177.SH): BAT5906 Receives Drug Clinical Trial Approval

Stock News
·
Aug 01

Chongqing Genrix Biopharmaceutical (688443.SH) Secures Clinical Trial Approval for Sleridimab Injection

Stock News
·
Jul 29

HK Movers|Pharma Stocks Shined. JWTherap Up 25%; TigerMed Up 9%; Microport Up 5%; JunShi Bio And Zai Lab Up 4%.

Tiger Newspress
·
Jul 29

HK Movers | Pharma Outsourcing Stocks Rise on Sector Optimism

Tiger Newspress
·
Jul 25

CANSINOBIO's Recombinant Polio Vaccine Secures Clinical Trial Approval in China

Stock News
·
Jul 16

CanSino Biologics (688185.SH) Secures NMPA Approval for Recombinant Trivalent Poliomyelitis Vaccine Clinical Trials

Stock News
·
Jul 16